Pharma Commercial Mock
IQVIA
Connected Intelligence™
National Prescription Audit
Source: NPA Weekly · Refresh: 2026-05-29·Marten Veskimae
Brand-level trends · ZENVARA

Weekly NPA dashboard · national

TRx (week)
2,091 9.3%
vs WK28, 2026-05-29
NRx (week)
651 14.2%
vs prior week
NBRx (week)
129 9.3%
new-to-brand
Cumulative TRx
7,973
4-week window
📈TRx — plan vs actual
09161,8332,74905-0805-1505-2205-29
Plan Actual
📊NRx ⨉ NBRx trend
05-0805-1505-2205-29
NRx NBRx
🍩Channel mix
RETAIL31%MAIL61%LTC8%
🗺️Geography — variance vs plan
WestMidwestNortheastSoutheast
Variance vs plan — darker = worse. Northeast highlighted as primary deviation region.
Weekly detail · 4 weeks
Week EndingTRxNRxNBRxPlan TRxVar %Cum TRx
2026-05-082,0315981262,497-18.7%2,031
2026-05-151,9385961242,498-22.4%3,969
2026-05-221,9135701182,498-23.4%5,882
2026-05-292,0916511292,499-16.3%7,973
© 2026 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union and various other countries. NPA™, Xponent™ and Connected Intelligence™ are trademarks of IQVIA Inc. This view is a demo mock and is not affiliated with IQVIA.